Naltrexone Hydrochloride Tablet — FDA Drug Shortage

Resolved — Chartwell Molecular Holdings LLC

The FDA lists a drug shortage record for Naltrexone Hydrochloride Tablet (tablet) from Chartwell Molecular Holdings LLC with status Resolved. The shortage was first posted on 02/29/2024.

Shortage Details

Status
Resolved
Company
Chartwell Molecular Holdings LLC
Package NDC
62135-242-60
Dosage Form
Tablet
Presentation
Naltrexone Hydrochloride, Tablet, 50 mg (NDC 62135-242-60)
Initial Posting
02/29/2024
Revised Date